Chiltern

Two from Chiltern win Clinical Researcher of the Year

Thursday, April 30, 2015 10:36 AM

Global CRO Chiltern has earned two Clinical Researcher of the Year (CRoY) winners in the U.K., joining the five finalists previously announced from the U.S. Sarah Jones earned the Gold Pharma in the CTA category and Helen Greenleaf earned Bronze as an Aspiring CRA. Both Chiltern Source professionals are working with Novartis.

More... »


Survey: PSI, INC Research, Chiltern rated top CROs by investigative sites

Wednesday, April 1, 2015 08:00 AM

More than 1,900 global investigative sites rate the best CROs for which to work in a new survey conducted by CenterWatch, a provider of global clinical trials information. The survey results were released in the April issue of The CenterWatch Monthly newsletter.

More... »


Glenn Kerkhof appointed chairman of the board

Monday, March 30, 2015 11:05 AM

George Clinical, a CRO focused on clinical development in the Asia-Pacific region, has appointed Glenn Kerkhof chairman of its board.

More... »

PharmaTimes clinical research awards to be presented Feb. 26

Thursday, February 12, 2015 03:33 PM

The 2015’s PharmaTimes Clinical Researcher of the Year—The Americas awards will be presented Feb. 26 in North Carolina.

More... »

Chiltern earns five spots in PharmaTimes Clinical Researcher of the Year finals

Thursday, January 29, 2015 10:47 AM

Chiltern, a global CRO, has earned five nominations in the PharmaTimes Clinical Researcher of the Year finals for the project manager, clinical research associate (CRA) and new CRA categories.

More... »

Chiltern launches rebranding

Monday, November 3, 2014 02:37 PM

U.K.-based Chiltern has rebranded as a completely integrated and unified CRO with services that are "Designed Around You.”

More... »

Chiltern acquires Pacific Clinical Research, expands in Asia-Pacific

Monday, September 29, 2014 01:24 PM

Chiltern, a global clinical CRO, has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific region and strengthens its oncology and anti-infective offerings.

More... »

Chiltern acquires Ockham, strengthening oncology, CRO services, job placement

Tuesday, July 15, 2014 03:38 PM

U.K.-based Chiltern, a 32-year-old global CRO specializing in oncology services and a range of other therapeutic areas, has acquired Ockham, a 28-year-old oncology-focused CRO, and the two companies will merge their operations.

More... »

Chiltern wins CRO leadership award from Life Science Leader

Friday, March 7, 2014 09:31 AM

Global CRO Chiltern has been recognized with a CRO Leadership Award in all five categories: Quality, Reliability, Productivity, Innovation and Regulatory. The awards are given by Life Science Leaderpublication based on the data-driven research of Nice Insight. Chiltern is the only organization to be recognized in all five categories for three straight years.

More... »

Chiltern partners with Karolinska Development

Thursday, February 13, 2014 01:59 PM

Global CRO Chiltern International has partnered with Karolinska Development, a Sweden-based life science investment company. Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. An exclusive deal flow agreement with Karolinska Institutet Innovations, along with other cooperation agreements with universities, delivers a continuous flow of innovations.

More... »


CWWeekly

July 6

FDA sued by advocacy groups seeking hepatitis C trials data

Google to test health-tracking wristband to collect clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs